Applied Genetic Technologies Corporation
AGTC
AGTC was delisted on the 30th of November, 2022.
61 hedge funds and large institutions have $59M invested in Applied Genetic Technologies Corporation in 2018 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 20 increasing their positions, 23 reducing their positions, and 9 closing their positions.
3,800% more call options, than puts
Call options by funds: $78K | Put options by funds: $2K
81% more capital invested
Capital invested by funds: $32.6M → $59M (+$26.4M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
5% less funds holding
Funds holding: 64 → 61 (-3)
13% less repeat investments, than reductions
Existing positions increased: 20 | Existing positions reduced: 23
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
Top Buyers
| 1 |
Wells Fargo
San Francisco,
California
|
+$934K |
| 2 |
Two Sigma Investments
New York
|
+$406K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
+$375K |
| 4 |
Renaissance Technologies
New York
|
+$320K |
| 5 |
Millennium Management
New York
|
+$201K |
Top Sellers
| 1 |
Man Group
London,
United Kingdom
|
-$1.13M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$565K |
| 3 |
6CM
683 Capital Management
New York
|
-$438K |
| 4 |
AL
AJO LP
Philadelphia,
Pennsylvania
|
-$324K |
| 5 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$268K |
AGTC Hedge Fund Activity: Q3 2018 in Review
61 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q3 2018, worth a combined $59M — up 81% from $32.6M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of AGTC and 7 opened new positions — a net loss of 2 holders — while 23 trimmed existing stakes and 20 added.
The largest buyer was Wells Fargo, adding an estimated $934K. The largest seller was Man Group, cutting an estimated $1.13M.
- 61 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q3 2018, down from 64 in Q2 2018.
- Funds reported $59M of Applied Genetic Technologies Corporation stock for Q3 2018, up 81% quarter-over-quarter.
- 7 funds opened new Applied Genetic Technologies Corporation positions in Q3 2018 and 9 closed out, a net change of -2 holders.
- The largest Applied Genetic Technologies Corporation buyer in Q3 2018 was Wells Fargo, an estimated $934K added.
- The largest Applied Genetic Technologies Corporation seller in Q3 2018 was Man Group, an estimated $1.13M sold.
Based on aggregated 13F filings for Q3 2018.